drugset / Trial / NCT05345210
Vonoprazan Hp Dual or Triple Eradication Regimes
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of dual or triple regimes for Helicobacter Pylori eradication using Vonoprazan as the antiacid agent.
Timeline
- Start
- 2022-04-25
- Primary completion
- 2023-02-28
- Completion
- 2023-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicillin | Other / unclassified | 1000 mg | Oral |
| Comparator | Clarithromycin | Small molecule | 500 mg | Oral |
| Subject | Furazolidone | Small molecule | 100 mg | Oral |
| Subject | Tetracycline | Unknown | 500 mg | Oral |
| Comparator | Vonoprazan | Other / unclassified | 20 mg | Oral |